While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss drugs of its own: Mounjaro and Zepbound. Mounjaro and Zepbound are by ...
Hosted on MSN6mon
How weight-loss drugs are changing the worldFuelled by blockbuster marvels like Ozempic and Mounjaro, which were developed ... including Wegovy and Zepound. But the current boom is just the beginning. Scores of other weight management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback